GO
Loading...

Regulations

More

  • July 23- The U.S. Food and Drug Administration said on Wednesday it has approved Gilead Sciences Inc's Zydelig, a drug to treat three types of blood cancer. The FDA approved the use of Zydelig in combination with Roche AG's Rituxan for patients with relapsed chronic lymphocytic leukemia.

  • July 23- The U.S. Securities and Exchange Commission has approved a new brokerage industry rule to ban dispute settlements between securities firms and investors that require investors to agree to erase complaints from brokers' public records.

  • SAN FRANCISCO/ FRANKFURT, July 22- European Union antitrust regulators are preparing to step up investigations of Google Inc's practices on several fronts and are likely to revise certain terms of a settlement involving its search engine that was proposed earlier this year, the Wall Street Journal reported on Tuesday.

  • German city Hamburg seeks to ban Uber ride service Wednesday, 23 Jul 2014 | 12:59 PM ET

    HAMBURG/ FRANKFURT, July 23- Hamburg has told Uber, a U.S. car service whose smartphone app summons rides at the touch of a button, to stop operating in the German city, adding to resistance the company has faced globally from local regulators and taxi drivers.

  • FDA approves Gilead Sciences drug for 3 cancers Wednesday, 23 Jul 2014 | 12:57 PM ET

    WASHINGTON— The Food and Drug Administration on Wednesday approved a new cancer drug from Gilead Sciences Inc. to treat three types of blood cancer. The FDA has approved three other drugs for the disease in the last year: Roche's Gazyva, Janssen Pharmaceutical's Imbruvica and GlaxoSmithKline's Arzerra.

  • U.S. FDA approves Gilead's blood cancer drug Zydelig Wednesday, 23 Jul 2014 | 12:05 PM ET

    July 23- The U.S. Food and Drug Administration has approved Gilead Inc's drug Zydelig to treat three types of blood cancer, the agency said on Wednesday. The FDA approved it for use in combination with Roche AG's Rituxan for patients with relapsed chronic lymphocytic leukemia.

  • SEC adopts money market reforms in 3-2 vote Wednesday, 23 Jul 2014 | 12:02 PM ET

    The SEC adopted rules designed to curb the risk of investor runs on money market funds.

  • Protections set up by the U.S. Food and Drug Administration called "risk evaluation and mitigation strategies", which can curb distribution of dangerous medicines, have been used to prevent generic drugmakers from getting the drugs in order to test their own versions, which is required to win FDA approval, the report from the Generic Pharmaceutical Association said.

  • WASHINGTON/ HONG KONG, July 23- A member of the U.S. Commodity Futures Trading Commission will become the new head of a bank lobby group that is fighting the derivatives regulator in court over a crucial new rule curtailing Wall Street.

  • July 23- Eagle Pharmaceuticals Inc said the U.S. Food and Drug Administration approved its drug to treat an inherited life-threatening condition called malignant hyperthermia. Eagle Pharmaceuticals is also testing Ryanodex for use in exertional heatstroke.

  • July 23- The International Swaps and Derivatives Association, a financial industry lobby group, named Commodity Futures Trading Commission commissioner Scott O'Malia as chief executive.

  • SEC votes to end $1 a share for some money funds Wednesday, 23 Jul 2014 | 12:03 AM ET

    WASHINGTON— Regulators have voted by a narrow margin to end a longtime staple of the investment industry— the fixed $1 share price for money-market mutual funds— at least for some money funds used by big investors.

  • U.S. SEC poised to adopt reforms for money market funds Wednesday, 23 Jul 2014 | 12:01 AM ET

    The reform will impact a wide variety of asset managers, from Blackrock Inc, Fidelity and Vanguard to Charles Schwab Corp, Pimco and Federated Investors Inc.. The two-pronged reform for the $2.6 trillion industry comes after a long battle between the SEC, the industry and federal banking regulators.

  • SHANGHAI, July 23- Food safety violations at Shanghai Husi Food Co Ltd, a supplier to global brands including McDonald's Corp and Yum Brands Inc, were company-led and not the acts of individuals, the official Xinhua news agency said, citing the Shanghai food and drug watchdog.

  • SHANGHAI, July 23- A Chinese food watchdog said food safety violations at Shanghai Husi Food Co Ltd, a supplier to global brands including McDonald's Corp and Yum Brands Inc, were company-led and not the acts of individuals, the official Xinhua news agency reported late on Tuesday.

  • The Federal Reserve Bank of New York has criticized Deutsche Bank of several reporting issues. CNBC's Mary Thompson reports the details.

  • WASHINGTON, July 22- The U.S. Chamber of Commerce made a last-ditch plea on Tuesday to federal securities regulators, urging them not to adopt rules that will change how some money market funds are valued and could cause companies to park their cash elsewhere.

  • SAN FRANCISCO, July 22- European Union antitrust regulators are preparing to step up investigations of Google Inc's practices on several fronts and are likely to revise certain terms of a settlement involving its search engine that was proposed earlier this year, the Wall Street Journal reported on Tuesday.

  • WASHINGTON, July 22- The U.S. Justice Department on Tuesday said it has intervened in a whistleblower lawsuit against Symantec Corporation that alleges the company submitted false claims to a government agency it worked with under contract.

  • TOKYO, July 22- McDonald's Holdings Co Ltd said Shanghai Husi Food Co Ltd, which was shut down by local regulators over food safety concerns, had supplied about 20 percent of its Chicken McNuggets and that it had halted sales of the item on Monday.